Related Experiment Video
Updated: May 8, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Malignant thyroid bed mass after total thyroidectomy.
Do Sung Park1, Jin Seong Cho, Min Ho Park
1Department of Surgery, Chonnam National University Medical School, Gwangju, Korea.
Journal of the Korean Surgical Society
|September 11, 2013
Summary
Ultrasonography can help identify malignant thyroid bed masses after papillary thyroid carcinoma surgery. Microcalcifications and increased height on ultrasound are key indicators for recurrence, suggesting fine-needle aspiration biopsy is crucial.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Papillary thyroid carcinoma (PTC) is a common thyroid malignancy.
- Recurrence in the thyroid bed after total thyroidectomy can occur.
- Ultrasonography (US) is a primary imaging modality for surveillance.
Purpose of the Study:
- To assess ultrasonographic (US) criteria for malignant thyroid bed masses post-total thyroidectomy for PTC.
- To investigate the relationship between US findings and fine-needle aspiration (FNA) cytology in thyroid bed masses.
Main Methods:
- Retrospective evaluation of 2,048 patients post-total thyroidectomy for PTC.
- US-guided fine-needle aspiration (FNA) performed on 97 suspicious thyroid bed masses.
- Comparison of US, clinical, and serologic findings between metastatic (n=34) and non-metastatic (n=63) thyroid bed groups.
Main Results:
- Malignant thyroid bed masses were associated with larger tumor size, isthmic position, and prior N1a status.
- US findings of microcalcification/macrocalcification and increased mass height were discriminative for central compartment recurrence.
- Echogenicity, hilum loss, and irregular margins were not significant predictors of malignancy.
Conclusions:
- US criteria for malignant thyroid bed masses differ from those for lateral metastatic nodes.
- Fine-needle aspiration cytology is recommended for suspicious thyroid bed masses, even in low-risk patients, based on specific US findings.
More Related Videos
Related Concept Videos
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

